Cargando…

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

BACKGROUND: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pomat, William S., van den Biggelaar, Anita H. J., Phuanukoonnon, Suparat, Francis, Jacinta, Jacoby, Peter, Siba, Peter M., Alpers, Michael P., Reeder, John C., Holt, Patrick G., Richmond, Peter C., Lehmann, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579820/ https://www.ncbi.nlm.nih.gov/pubmed/23451070 http://dx.doi.org/10.1371/journal.pone.0056698

Ejemplares similares

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants
por: Pomat, William S, et al.
Publicado: (2019)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
por: Orami, Tilda, et al.
Publicado: (2020)

Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in Papua New Guinean children: A randomized controlled trial
por: Aho, Celestine, et al.
Publicado: (2016)

Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2019)

Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea
por: van den Biggelaar, Anita. H.J., et al.
Publicado: (2009)

A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study
por: Francis, Jacinta P., et al.
Publicado: (2016)

Differences in Pneumococcal and Haemophilus influenzae Natural Antibody Development in Papua New Guinean Children in the First Year of Life
por: Martinovich, Kelly M., et al.
Publicado: (2021)

Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance
por: van den Biggelaar, Anita H.J., et al.
Publicado: (2011)

An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea
por: Javati, Sarah, et al.
Publicado: (2020)

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
por: Lehmann, Deborah, et al.
Publicado: (2017)

Ontogeny of Toll-Like and NOD-Like Receptor-Mediated Innate Immune Responses in Papua New Guinean Infants
por: Lisciandro, Joanne G., et al.
Publicado: (2012)

Streptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era
por: Greenhill, Andrew R., et al.
Publicado: (2015)

Respiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New Guinea
por: Chidlow, Glenys R., et al.
Publicado: (2012)

Chitotriosidase deficiency is not associated with human hookworm infection in a Papua New Guinean population
por: Hall, Andrew J., et al.
Publicado: (2007)

Papua New Guinean Genomes Reveal the Complex Settlement of North Sahul
por: Brucato, Nicolas, et al.
Publicado: (2021)

Cord blood Streptococcus pneumoniae‐specific cellular immune responses predict early pneumococcal carriage in high‐risk infants in Papua New Guinea
por: Francis, J. P., et al.
Publicado: (2016)

Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea
por: Pell, Christopher, et al.
Publicado: (2010)

Characterization of the Gut Microbiota of Papua New Guineans Using Reverse Transcription Quantitative PCR
por: Greenhill, Andrew R., et al.
Publicado: (2015)

Use of Antibiotics within the IMCI Guidelines in Outpatient Settings in Papua New Guinean Children: An Observational and Effectiveness Study
por: Senn, Nicolas, et al.
Publicado: (2014)

Subacute Sclerosing Panencephalitis in Papua New Guinean Children: The Cost of Continuing Inadequate Measles Vaccine Coverage
por: Manning, Laurens, et al.
Publicado: (2011)

Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children
por: Lin, Enmoore, et al.
Publicado: (2010)

Intermittent Preventive Treatment for Malaria in Papua New Guinean Infants Exposed to Plasmodium falciparum and P. vivax: A Randomized Controlled Trial
por: Senn, Nicolas, et al.
Publicado: (2012)

Risk factors and pregnancy outcomes associated with placental malaria in a prospective cohort of Papua New Guinean women
por: Lufele, Elvin, et al.
Publicado: (2017)

Correction: Intermittent Preventive Treatment for Malaria in Papua New Guinean Infants Exposed to Plasmodium falciparum and P. vivax: A Randomized Controlled Trial
por: Senn, Nicolas, et al.
Publicado: (2012)

Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children
por: França, Camila T., et al.
Publicado: (2016)

Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea
por: Ballif, Marie, et al.
Publicado: (2012)

Reduced Risk of Plasmodium vivax Malaria in Papua New Guinean Children with Southeast Asian Ovalocytosis in Two Cohorts and a Case-Control Study
por: Rosanas-Urgell, Anna, et al.
Publicado: (2012)

A High Force of Plasmodium vivax Blood-Stage Infection Drives the Rapid Acquisition of Immunity in Papua New Guinean Children
por: Koepfli, Cristian, et al.
Publicado: (2013)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
por: Laman, Moses, et al.
Publicado: (2014)

Severe Anemia in Papua New Guinean Children from a Malaria-Endemic Area: A Case-Control Etiologic Study
por: Manning, Laurens, et al.
Publicado: (2012)

Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea
por: Ley, Serej D, et al.
Publicado: (2014)

Diarrhoeal disease surveillance in Papua New Guinea: findings and challenges
por: Abdad, Mohammad Yazid, et al.
Publicado: (2020)

Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children
por: Manning, Laurens, et al.
Publicado: (2011)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
por: Laman, Moses, et al.
Publicado: (2014)

Ethical challenges in integrating patient-care with clinical research in a resource-limited setting: perspectives from Papua New Guinea
por: Laman, Moses, et al.
Publicado: (2013)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study
por: Laman, Moses, et al.
Publicado: (2015)

Rapid Antigen Detection Tests for Malaria Diagnosis in Severely Ill Papua New Guinean Children: A Comparative Study Using Bayesian Latent Class Models
por: Manning, Laurens, et al.
Publicado: (2012)

Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study
por: Blyth, Christopher C, et al.
Publicado: (2022)

Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children
por: Ome-Kaius, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hb8dngeohvmc3mv1j7930judfq